KERYX BIOPHARMACEUTICALS INC Increase (Decrease) in Derivative Liabilities
KERYX BIOPHARMACEUTICALS INC reported Increase (Decrease) in Derivative Liabilities of $0 for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDerivativeLiabilities · last filed 2018-11-08
- KERYX BIOPHARMACEUTICALS INC increase (decrease) in derivative liabilities for the quarter ending 2018-09-30 was $0.00.
- KERYX BIOPHARMACEUTICALS INC increase (decrease) in derivative liabilities for the quarter ending 2018-06-30 was $0.00.
- KERYX BIOPHARMACEUTICALS INC increase (decrease) in derivative liabilities for the quarter ending 2017-12-31 was $0.00.
- KERYX BIOPHARMACEUTICALS INC increase (decrease) in derivative liabilities for the quarter ending 2017-09-30 was $0.00.
- KERYX BIOPHARMACEUTICALS INC increase (decrease) in derivative liabilities for fiscal 2017 was -$225.00K, a 104.77% decline from fiscal 2016.
- KERYX BIOPHARMACEUTICALS INC increase (decrease) in derivative liabilities for fiscal 2016 was $4.72M, a 328.13% increase from fiscal 2015.
- KERYX BIOPHARMACEUTICALS INC increase (decrease) in derivative liabilities for fiscal 2015 was $1.10M.
- KERYX BIOPHARMACEUTICALS INC increase (decrease) in derivative liabilities for fiscal 2014 was $0.00.
| Period end | Increase (Decrease) in Derivative Liabilities 3 month | Increase (Decrease) in Derivative Liabilities 6 month | Increase (Decrease) in Derivative Liabilities 9 month | Increase (Decrease) in Derivative Liabilities 12 month |
|---|---|---|---|---|
| 2018-09-30 | $0.00 10-Q · filed 2018-11-08 | $0.00 derived: sum of 2 quarters · filed 2018-11-08 | $0.00 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-09 | $0.00 10-Q · filed 2018-08-09 | ||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | $0.00 derived: sum of 2 quarters · filed 2018-11-08 | -$225.00K derived: sum of 3 quarters · filed 2018-11-08 | -$225.00K 10-K · filed 2018-02-21 |
| 2017-09-30 | $0.00 10-Q · filed 2018-11-08 | -$225.00K derived: sum of 2 quarters · filed 2018-11-08 | -$225.00K 10-Q · filed 2018-11-08 | -$225.00K derived: sum of 4 quarters · filed 2018-11-08 |
| 2017-06-30 | -$225.00K 10-Q · filed 2018-08-09 | -$225.00K 10-Q · filed 2018-08-09 | -$225.00K derived: sum of 3 quarters · filed 2018-08-09 | -$225.00K derived: sum of 4 quarters · filed 2018-08-09 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-04 | $0.00 derived: sum of 2 quarters · filed 2018-02-21 | $0.00 derived: sum of 3 quarters · filed 2018-02-21 | $2.71M derived: sum of 4 quarters · filed 2018-02-21 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | $0.00 derived: sum of 2 quarters · filed 2018-02-21 | $2.71M derived: sum of 3 quarters · filed 2018-02-21 | $4.72M 10-K · filed 2018-02-21 |
| 2016-09-30 | $0.00 10-Q · filed 2017-11-07 | $2.71M derived: sum of 2 quarters · filed 2017-11-07 | $4.72M 10-Q · filed 2017-11-07 | |
| 2016-06-30 | $2.71M 10-Q · filed 2017-07-27 | $4.72M 10-Q · filed 2017-07-27 | ||
| 2016-03-31 | $2.01M 10-Q · filed 2017-05-04 | |||
| 2015-12-31 | $1.10M 10-K · filed 2018-02-21 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-03-01 |